Capybara Research said in a recently published report that it sees “problems at Nutex.” “Over a dozen Nutex partners, including physicians, medical directors, and board members, have accused Nutex and its CEO and Chairman, Thomas Vo of wrongdoing including fraud, embezzlement, and self-dealing. The allegations are corroborated by multiple independent sources including former insiders with first-hand knowledge. The allegations are also consistent over time, showing a pattern of misconduct spanning over 10 years… Nutex’s reputation is catching up with it and partners are fighting back. We believe it’s only a matter of time before more physician groups and ERs part ways with the company, causing others to follow their lead,” the report reads. Overall, Capybara says that, “after extensive research including interviews with former insiders and partners, we believe that Nutex Health (NUTX) and its founder CEO have engaged in a pattern of fraudulent and unethical business practices.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUTX:
